TriSalus Life Sciences, Inc. (TLSI) has 36 open-market insider trades by 15 insiders since 2024. Over the last six months insiders net bought $1.8M. The most active filer is Mary T. Szela, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael P. Stansky | Dir | — | 2 | $3.0M | 2026-05-15 |
| Mary T. Szela | CEOPres | — | 7 | $509K | 2026-06-30 |
| Equity Ab Frankenius | 10% Owner | — | 1 | $500K | 2024-12-17 |
| James Emmett Young | CFO | — | 2 | $293K | 2025-05-19 |
| Mats Wahlstrom | Dir | — | 3 | $222K | 2026-05-15 |
| Sean Murphy | — | — | 1 | $157K | 2025-05-19 |
| William Valle | Dir | — | 1 | $125K | 2026-05-14 |
| Arjun Jj Desai | Dir | — | 1 | $111K | 2024-12-10 |
| Gary B. Gordon | Dir | — | 2 | $65K | 2026-05-15 |
| Jennifer Stevens | — | — | 3 | $61K | 2026-10-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jennifer Stevens | — | Sell | $1K | 2026-10-05 |
| Bryan F. Cox | — | Sell | $1K | 2026-10-05 |
| Richard Marshak | CCO | Sell | $1K | 2026-10-05 |
| Michael P. Stansky | Director | Buy | $1.5M | 2026-05-15 |
| Mats Wahlstrom | Director | Buy | $152K | 2026-05-15 |
| Mary T. Szela | CEO & President | Buy | $103K | 2026-05-15 |
Companies that share insiders with TLSI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Gary B. Gordon | Director | Buy | $25K | 2026-05-15 |
| David Patience | CFO | Buy | $17K | 2026-05-15 |
| Richard Marshak | CCO | Sell | $1K | 2026-05-15 |
| Richard Marshak | CCO | Sell | $14K | 2026-03-11 |
| Jennifer Stevens | — | Sell | $15K | 2026-03-11 |
| Bryan F. Cox | — | Sell | $13K | 2026-03-11 |
| Jodi Devlin | — | Sell | $13K | 2026-03-11 |
| Mary T. Szela | CEO & President | Sell | $79K | 2026-03-11 |
| David Patience | CFO | Buy | $15K | 2026-02-23 |